Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Despite the availability and demonstrated effectiveness of office-based buprenorphine maintenance treatment (BMT), the systematic examination of physicians’ attitudes towards this new medical practice has been largely neglected.
To identify facilitators and barriers to the potential or actual implementation of BMT by office-based medical providers.
Qualitative study using individual and group semi-structured interviews.
Twenty-three practicing office-based physicians in New England.
Interviews were audiotaped, transcribed, and entered into a qualitative software program. The transcripts were thematically coded using the constant comparative method by a multidisciplinary team.
Eighty percent of the physicians were white; 55% were women. The mean number of years since graduating medical school was 14 (SD = 10). The primary areas of clinical specialization were internal medicine (50%), infectious disease (20%), and addiction medicine (15%). Physicians identified physician, patient, and logistical factors that would either facilitate or serve as a barrier to their integration of BMT into clinical practice. Physician facilitators included promoting continuity of patient care, positive perceptions of BMT, and viewing BMT as a positive alternative to methadone maintenance. Physician barriers included competing activities, lack of interest, and lack of expertise in addiction treatment. Physicians’ perceptions of patient-related barriers included concerns about confidentiality and cost, and low motivation for treatment. Perceived logistical barriers included lack of remuneration for BMT, limited ancillary support for physicians, not enough time, and a perceived low prevalence of opioid dependence in physicians’ practices.
Addressing physicians’ perceptions of facilitators and barriers to BMT is crucial to supporting the further expansion of BMT into primary care and office-based practices.
- Diagnostic and Statistical Manual of Mental Disorders (text revision). Author, Washington, DC
- Sullivan, LE, Chawarski, M, O’Connor, PG, Schottenfeld, RS, Fiellin, DA (2005) The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?. Drug Alcohol Depend 79: pp. 113-116 CrossRef
- Becker, WC, Sullivan, LE, Tetrault, JM, Desai, RA, Fiellin, DA (2007) Non-medical use, abuse and dependence on prescription opioids among US adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend 94: pp. 38-47 CrossRef
- Martell, BA, O’Connor, PG, Kerns, RD, Becker, WC, Morales, KH, Kosten, TR, Fiellin, DA (2007) Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 146: pp. 116
- Fiellin, DA, O’Connor, PG (2002) Office-based treatment of opioid-dependent patients. N Engl J Med 347: pp. 817-823 CrossRef
- Sullivan, LE, Moore, BA, Chawarski, MC, Pantalon, MV, Barry, D, O’Connor, PG, Schottenfeld, RS, Fiellin, DA (2008) Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. J Subst Abuse Treat 35: pp. 87-92 CrossRef
- O’Connor, PG, Fiellin, DA (2000) Pharmacologic treatment of heroin-dependent patients. Ann Intern Med 133: pp. 40-54
- Sullivan, LE, Metzger, DS, Fudala, PJ, Fiellin, DA (2005) Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Addiction 100: pp. 150-158 CrossRef
- NIH Consensus Panel. Effective medical treatment of opiate addiction. National Consensus Development Panel of Effective Medical Treatment of Opiate Addiction. 1998;280:1936–43.
- Office of National Drug Control Policy. Policy Paper –Opioid Agonist Treatment. Washington, D.C.: Executive Office of the President, Office of National Drug Control Policy; March, 1999.
- Rettig RA, Yarmolinsky A, eds. Federal Regulation of Methadone Treatment. Washington, DC: Institute of Medicine, National Academy Press; 1995.
- Brady, KT (2007) Medical treatment of opiate dependence: expanding treatment options. Am J Psych 164: pp. 702-704 CrossRef
- Fiellin, DA (2007) The first 3 years of buprenorphine in the United States: experience to date and future directions. J Addict Medicine 1: pp. 62-67 CrossRef
- Fiellin, D, Pantalon, MV, Chawarski, M (2006) Buprenorphine maintenance in primary care: a randomized controlled trial of counseling conditions and medication dispensing. N Engl J Med 355: pp. 365-374 CrossRef
- Fiellin, DA, O’Connor, PG, Chawarski, M, Pakes, JP, Pantalon, MV, Schottenfeld, RS (2001) Methadone maintenance in primary care a randomized controlled trial. JAMA 286: pp. 1724-1731 CrossRef
- Fiellin, DA, Pantalon, MV, Pakes, JP, O’Connor, PG, Chawarksi, M, Schottenfeld, RS (2002) Treatment of heroin dependence with buprenorphine in primary care. Am J Drug Alcohol Abuse 28: pp. 231-242 CrossRef
- O’Connor, PG, Oliveto, AH, Shi, JM, Triffleman, EG, Carroll, KM, Kosten, TR, Rounsaville, BJ, Pakes, JA, Schottenfeld, RS (1998) A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am J Med 105: pp. 100-105 CrossRef
- Glaser, BG, Strauss, AL (1967) The Discovery of Grounded Theory: Strategies for Qualitative Research. Aldine Publishing Company, New York
- Duszynski, KR, Nieto, F, Valente, CM (1995) Reported practices, attitudes, and confidence levels of primary care physicians regarding patients who abuse alcohol and other drugs. Md Med J 44: pp. 439-446
- McMurphy, S, Shea, J, Switzer, J, Turner, BJ (2006) Clinic-based treatment for opioid dependence: a qualitative inquiry. Am J Health Behav 30: pp. 544-554
- Miller, NS, Sheppard, LM, Colenda, CC, Magen, J (2001) Why physicians are unprepared to treat patients who have alcohol-and drug-related disorders. Acad Med 7: pp. 410-418 CrossRef
- Karam-Hage, M, Nerenberg, L, Brower, KJ (2001) Modifying residents’ professional attitudes about substance abuse treatment and training. Am J Addict 10: pp. 40-47 CrossRef
- Parish, SJ, Ramaswamy, M, Stein, MR, Kachur, EK, Arnsten, JH (2006) Teaching about substance abuse with objective structured clinical exams. J Gen Intern Med 21: pp. 453-459 CrossRef
- Cunningham, CO, Kunins, HV, Roose, RJ, Elam, RT, Sohler, NL (2007) Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians. J Gen Intern Med 22: pp. 1325-1329 CrossRef
- Egan J, Netherland J, Finkelstein R, Fiellin D. Facilitating buprenorphine implementation: The physician Clinical Support System. College on Problems of Drug Dependence Annual Meeting, June 18, 2006, Scottsdale, Arizona.
- Netherland J, Botsko M, Egan J, Saxon A, Cunningham CO, Finkelstein R, Gourevitch MN, Renner J, Sohler NL, Sullivan LE, Weiss L, Fiellin D, (in press). Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat.
- McCance-Katz, EF (2004) Office-based buprenorphine treatment for opioid-dependent patients. Harv Rev Psychiatry 12: pp. 321-338 CrossRef
- Barry, DT, Moore, BA, Pantalon, MV, Chawarski, MC, Sullivan, LE, O’Connor, PG, Schottenfeld, RS, Fiellin, DA (2007) Patient satisfaction with primary care office-based buprenorphine/naloxone treatment. J Gen Intern Med 22: pp. 242-245 CrossRef
- Becker, WC, Fiellin, DA (2006) Provider satisfaction with office-based treatment of opioid dependence: a systematic review. Subst Abuse 26: pp. 15-22 CrossRef
- Chou, WC, Tinetti, ME, King, MB, Irwin, K, Fortinsky, RH (2006) Perceptions of physicians on the barriers and facilitators to integrating fall risk evaluation and management into practice. J Gen Intern Med 21: pp. 117-122
- Yarnall, KSH, Pollak, KI, Ostbye, T, Krause, KM, Michener, JL (2003) Primary care: is there enough time for prevention?. Am Public Health Assoc 93: pp. 635-641 CrossRef
- McPherson, TL, Hersch, RK (2000) Brief substance use screening instruments for primary care settings a review. J Subst Abuse Treat 18: pp. 193-202 CrossRef
- Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study
Journal of General Internal Medicine
Volume 24, Issue 2 , pp 218-225
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- opioid-related disorders
- qualitative research
- Industry Sectors
- Author Affiliations
- 1. Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
- 3. Community Health Program, Tufts University, Medford, MA, USA
- 2. Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
- 4. Department of Psychiatry, New York University School of Medicine, New York, NY, USA